top of page

Serda Lab

Our lab has a strong commitment to creating novel therapeutic approaches for cancer immunotherapy in hopes of someday contributing to a cure for metastatic cancer.

imsn.png

Rita Serda Lab

Our team has developed a cell silicification process that maintains cell integrity, preserves cellular contents, renders cells non-viable and stable to dehydration and storage at room temperature; and enhances surface adsorption of molecules, such as pathogen-associated molecular patterns (PAMPs), creating immune stimulatory microbial mimetic personalized immune therapeutics

Rita 2_edited.jpg

News

Podcast Appearance 

The University of New Mexico's podcast featuring Dr. Sarah Adams, discusses the novelty of using silicified "zombie" cancer cells as personalized immune therapy and its contributions towards shaping clinical trials and establishing novel ovarian cancer treatments. 
probably-not-rocket-science-pod-branding-cherry.jpg

CU Anschutz ASPIRE Award

aspire award.png
Team Member

This Specialized Programs of Research Excellence Award at the University of Colorado support projects that utilize a novel therapeutic approach towards treating ovarian cancer and aims to progress treatments towards clinical trials.

The Kleh Family Foundation

Patricia-Kleh-William-Kleh7.jpg

Thank you to William and Patricia Kleh of the Kleh Family Foundation, for your philanthropic donation to support clinical translation of silicified cancer cell immune therapy.

KUNM Feature

KUNM radio segment featuring Dr. Rita Serda and Dr. Sarah Adams - with a discussion on how "zombie cancer vaccines" preserve patient tumor antigens and initiate a systemic immune response when returned to the patient. 

KUNM_logo.png
dc + vac 180 pt pd 3kv 20nA _purple green copy.png

The Work in Our Lab is Supported By:

The National Institute of Health
The Kleh Family Foundation
The Oxnard Foundation

​

© 2035 by The Thomas Hill. Powered and secured by Wix

bottom of page